anchor: And, primarily because of the daunting scientific obstacles, woefully few companies have an aggressive AIDS-vaccine program.
positive: Primarily because of the scientific challenges, few companies invest in AIDS vaccine programs.
negative: Companies have been readily investing in AIDS vaccine research.